Sun Pharmaceutical Industries jumped during the afternoon session with the stock price gaining over 3 percent.
On Monday, domestic stock markets experienced a severe drop as the S&P BSE Sensex fell over 1,100 points in morning trade, eventually sliding 1,300 points to 78,420, while the NSE Nifty50 decli
Prabhudas Lilladher reaffirms its "Buy" stance on Sun Pharmaceutical Industries Ltd. (SUNP), revising the target price to Rs.2,100 from Rs.1,885.
ITC, Axis Bank, Asian Paints, TCS and Sun Pharmaceuticals were offering support to markets in today’s trading session.
Market expert Kushal Gupta has suggested five BUY Calls and no SELL Call for today’s trading session.
Technical analyst Sudarshan Sukhani has suggested two BUY Calls and two SELL Calls for today’s trading session.
